Infectious Disease Puscast #31

June 28, 2023

On episode #31 of the Infectious Disease Puscast, Daniel and Sara review the infectious disease literature for the weeks of 6/8 – 6/20/23.

Hosts: Daniel Griffin and Sara Dong

Click arrow to play
Download Puscast 031 (22 MB .mp3, 36 min)
Subscribe (free): Apple Podcasts, Google Podcasts, RSS, email

Become a patron of Puscast!

  • Relative effectiveness of the cell-based quadrivalent influenza vaccine in preventing cardiorespiratory hospitalizations (OFID)
  • Evaluation of Oseltamivir used to prevent hospitalization in outpatients with influenza (JAMA)
  • Pan-ebolavirus monoclonal antibody cocktail provides protection against Ebola and Sudan viruses (JID)
  • Inappropriate antibiotic prescribing and its determinants among outpatient children in low-and middle-income countries (PLOS)
  • IDSA 2023 Guidance on the treatment of antimicrobial resistant gram-negative infections (IDSA)
  • Evaluating antimicrobial duration for gram-negative bacteremia in patients with neutropenia (TID)
  • Antibiotic myths for the ID clinician (CID)
  • Dalbavancin for the treatment of acute bacterial skin and skin structure infection in patients with obesity or Diabetes (OFID)
  • Global differences in the management of S. aureus bacteremia (CID)
  • Clinical risk Scores to Predict Trimethoprim-Sulfamethoxazole, Fluoroquinolone, Nitrofurantoin, and Cephalosporin non-susceptibility among outpatient episodes of complicated UTI among adults (OFID)
  • Continuous vs intermittent meropenem administration in critically ill patients with sepsis (JAMA)
  • Current pyuria cutoffs promote inappropriate UTI diagnosis in older women (CID)
  • Paenibacillus infection as a novel cause of sepsis in term neonates with high risk of sequelae in Uganda (CID)
  • Antimicrobial for 7 or 14 Days for febrile urinary tract infection in men (CID)
  • Candida auris‒associated hospitalizations (EID)
  • Fatal invasive mold infections after transplantation of organs recovered from drowned donors (EID)

Music is by Ronald Jenkees

Leave a Reply

Your email address will not be published. Required fields are marked *

Content on this site is licensed by MicrobeTV, Inc. under a Creative Commons Attribution 3.0 License.